enVVeno Medical 

$10.85
0
+$0+0% Monday 04:00

Statistics

Day High
10.92
Day Low
10.85
52W High
-
52W Low
-
Volume
8
Avg. Volume
-
Mkt Cap
219.34M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4MayExpected
Q3 2025
Next
-10.5
-9.8
-9.1
-8.4
Expected EPS
-8.4
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-43.64MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NVNO.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.33B
Medtronic is a major player in the medical devices sector, offering products that can compete directly with enVVeno Medical's neurovascular and cardiovascular solutions.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific competes in the medical devices market, particularly in areas overlapping with enVVeno Medical's focus on neurovascular treatments.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories offers a wide range of medical devices, including those for cardiovascular and neuromodulation, making it a direct competitor.
Smith & Nephew
SNN
Mkt Cap15.61B
Smith & Nephew operates in the medical technology field, with products that could compete in the surgical sectors where enVVeno Medical may be involved.
Stryker
SYK
Mkt Cap136.19B
Stryker is known for its medical devices and equipment, competing in the neurotechnology and spine sector, which may overlap with enVVeno Medical's offerings.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its medical devices segment, competes across a broad range of healthcare products, including those that could be in direct competition with enVVeno Medical.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet Holdings, Inc. competes in the musculoskeletal healthcare sector, which could include products and technologies competitive with enVVeno Medical's.
Edwards Lifesciences
EW
Mkt Cap48.41B
Edwards Lifesciences specializes in heart valves and hemodynamic monitoring, areas that could see overlap with enVVeno Medical's cardiovascular solutions.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical, known for its da Vinci surgical systems, competes in the innovative surgical solutions space, potentially overlapping with enVVeno Medical's market.
Integra Lifesciences
IART
Mkt Cap935.48M
Integra LifeSciences, a provider of regenerative technologies, neurosurgical, and extremity orthopedic solutions, competes in areas that may overlap with enVVeno Medical's focus.

About

enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.
Show more...
CEO
ISIN
US29415J2050

Listings

0 Comments

Share your thoughts

FAQ

What is enVVeno Medical stock price today?
The current price of NVNO.BOATS is $10.85 USD — it has increased by +0% in the past 24 hours. Watch enVVeno Medical stock price performance more closely on the chart.
What is enVVeno Medical stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange enVVeno Medical stocks are traded under the ticker NVNO.BOATS.
What is enVVeno Medical market cap?
Today enVVeno Medical has the market capitalization of 219.34M
When is the next enVVeno Medical earnings date?
enVVeno Medical is going to release the next earnings report on May 04, 2026.
What is enVVeno Medical revenue for the last year?
enVVeno Medical revenue for the last year amounts to 0 USD.
What is enVVeno Medical net income for the last year?
NVNO.BOATS net income for the last year is -43.64M USD.
When did enVVeno Medical complete a stock split?
enVVeno Medical has not had any recent stock splits.